These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 1708190)

  • 1. Effects of clomipramine treatment on cerebrospinal fluid monoamine metabolites and platelet 3H-imipramine binding and serotonin uptake and concentration in major depressive disorder.
    Mårtensson B; Wägner A; Beck O; Brodin K; Montero D; Asberg M
    Acta Psychiatr Scand; 1991 Feb; 83(2):125-33. PubMed ID: 1708190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine.
    Asberg M; Ringberger VA; Sjöqvist F; Thorén P; Träskman L; Tuck JR
    Clin Pharmacol Ther; 1977 Feb; 21(2):201-7. PubMed ID: 13959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. II. Biochemical findings.
    Aberg-Wistedt A; Ross SB; Jostell KG; Sjöquist B
    Acta Psychiatr Scand; 1982 Jul; 66(1):66-82. PubMed ID: 6181652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical effects of antidepressant treatment--studies of monoamine metabolites in cerebrospinal fluid and platelet [3H]imipramine binding.
    Asberg M; Wägner A
    Ciba Found Symp; 1986; 123():57-83. PubMed ID: 2434288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fluoxetine treatment of platelet 3H-imipramine binding, 5-HT uptake and 5-HT content in major depressive disorder.
    Wgner A; Montero D; Mårtensson B; Siwers B; Asberg M
    J Affect Disord; 1990 Oct; 20(2):101-13. PubMed ID: 2176228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluid.
    Mårtensson B; Nyberg S; Toresson G; Brodin E; Bertilsson L
    Acta Psychiatr Scand; 1989 Jun; 79(6):586-96. PubMed ID: 2475012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between clinical symptoms and monoamine metabolite concentrations in biochemically defined subgroups of depressed patients.
    Nordin C
    Acta Psychiatr Scand; 1988 Dec; 78(6):720-9. PubMed ID: 2464903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects.
    Thorén P; Asberg M; Bertilsson L; Mellström B; Sjöqvist F; Träskman L
    Arch Gen Psychiatry; 1980 Nov; 37(11):1289-94. PubMed ID: 6159865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in [3H]5-HT uptake and [3H]imipramine binding in platelets after chlorimipramine in healthy volunteers. Comparison with maprotiline and amineptine.
    Poirier MF; Galzin AM; Loo H; Pimoule C; Segonzac A; Benkelfat C; Sechter D; Zarifian E; Schoemaker H; Langer SZ
    Biol Psychiatry; 1987 Mar; 22(3):287-302. PubMed ID: 3028514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased plasma serotonin in melancholic patients: a study with clomipramine.
    Sarrias MJ; Artigas F; Martínez E; Gelpí E; Alvarez E; Udina C; Casas M
    Biol Psychiatry; 1987 Dec; 22(12):1429-38. PubMed ID: 3676370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced inhibitory effect of imipramine on radiolabeled serotonin uptake into platelets in geriatric depression.
    Slotkin TA; Whitmore WL; Barnes GA; Krishnan KR; Blazer DG; Knight DL; Nemeroff CB
    Biol Psychiatry; 1989 Mar; 25(6):687-91. PubMed ID: 2538161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memory effects of clomipramine treatment: relationship to CSF monoamine metabolites and drug concentrations in plasma.
    Bartfai A; Asberg M; Mårtensson B; Gustavsson P
    Biol Psychiatry; 1991 Dec; 30(11):1075-92. PubMed ID: 1723300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of paroxetine on cerebrospinal fluid concentrations of neurotransmitter metabolites in depressed patients.
    Lundmark J; Wålinder J; Alling C; Manniche PM; Dalgaard L
    Eur Neuropsychopharmacol; 1994 Mar; 4(1):1-6. PubMed ID: 7515737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of imipramine and trazodone on the re-uptake of (3H) serotonin by thrombocytes in patients with endogenous depression: changes in antidepressive therapy].
    Katasonow AB; Brusow OS; Beljaew BS; Slobina GP; Faktor MI; Larionowa TB; Trunte K; Lidemann RR
    Psychiatr Neurol Med Psychol (Leipz); 1989 Apr; 41(4):210-7. PubMed ID: 2544916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium addition in antidepressant-resistant depression: effects on platelet 5-HT, plasma 5-HT and plasma 5-HIAA concentration.
    Birkenhäger TK; van den Broek WW; Fekkes D; Mulder PG; Moleman P; Bruijn JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1084-8. PubMed ID: 17467132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromocriptine treatment of depressive disorders. Clinical and biochemical effects.
    Nordin C; Siwers B; Bertilsson L
    Acta Psychiatr Scand; 1981 Jul; 64(1):25-33. PubMed ID: 6172006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid levels of monoamine metabolites in panic disorder.
    Eriksson E; Westberg P; Alling C; Thuresson K; Modigh K
    Psychiatry Res; 1991 Mar; 36(3):243-51. PubMed ID: 1712114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alaproclate a novel antidepressant? A biochemical and clinical comparison with zimeldine.
    Aberg-Wistedt A; Alvariza M; Bertilsson L; Malmgren R; Wachtmeister H
    Acta Psychiatr Scand; 1985 Mar; 71(3):256-68. PubMed ID: 2580422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of antidepressant treatments on platelet tritiated imipramine binding in major depressive disorder.
    Wägner A; Aberg-Wistedt A; Asberg M; Bertilsson L; Mårtensson B; Montero D
    Arch Gen Psychiatry; 1987 Oct; 44(10):870-7. PubMed ID: 2821953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers.
    De Bellis MD; Geracioti TD; Altemus M; Kling MA
    Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):636-41. PubMed ID: 7687151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.